Tag: licensing
-
U.S. to Buy Covid-19 Antiviral Drug in $1.2B Deal
Two U.S. government health agencies agreed to purchase some 1.7 million doses of a Covid-19 antiviral drug, once the drug receives clearance from FDA.
-
Gene Therapy Company Starts-Up, Gains $200M
A new company is underway commercializing research on gene therapies for inherited diseases, staked to an initial investment of $200 million.
-
Biotechs Partner on Gene-Edited Cancer Cell Therapies
Two biotechnology companies are collaborating on using the gene editing technique Crispr to create engineered immune-system cells to treat cancer.
-
AI Gene Therapy Platform Gains $100M in Early Funds
A company using machine learning to create engineered viruses to deliver gene therapies is raising $100 million in its first venture funding round.
-
Gene Therapy Company Exploring DNA Circuit Technology
Spark Therapeutics, a developer of gene therapies, is gaining access to a technology that programs DNA sequences like integrated electronic circuits.
-
Arthritis Drug Unsuccessful for Covid-19 Hospital Patients
A clinical trial shows a drug designed to reduce inflammation in autoimmune disease patients does not clearly help patients hospitalized with Covid-19 disease.
-
Infectious Disease Biotech Raises $100M in Venture Funds
A biotechnology company designing vaccines for viral diseases including Covid-19 is raising $100 million in its second venture funding round.
-
Univ. Lab Develops, Licenses Sports Injury Implant
A medical device company now offers a synthetic tissue implant for torn rotator cuff, a common sports injury, designed at a Purdue University engineering lab.
-
Vaccine Spin-Off Raises $168 Million in New Funds
A developer of vaccines, including a leading Covid-19 vaccine, and cancer immunotherapies, is raising $168 million in its second venture round.
-
New Covid-19 mRNA Vaccine Trial Begins
A clinical trial is underway testing a new Covid-19 vaccine based on messenger RNA, developed by biotech company Translate Bio and drug maker Sanofi.